1 / 51

Musculoskeletal: Autoimmune; Inflammatory; Metabolic; Infectious Disorders

Musculoskeletal: Autoimmune; Inflammatory; Metabolic; Infectious Disorders. Rheumatoid Arthritis; SLE; Paget’s Disease; Gout; Osteomyelitis. Carolyn Morse Jacobs, RN, MSN, ONC 10/ 24/ 04. Autoimmune and Inflammatory Disorders: Rheumatoid Arthritis.

Audrey
Download Presentation

Musculoskeletal: Autoimmune; Inflammatory; Metabolic; Infectious Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Musculoskeletal: Autoimmune; Inflammatory; Metabolic; Infectious Disorders Rheumatoid Arthritis; SLE; Paget’s Disease; Gout; Osteomyelitis Carolyn Morse Jacobs, RN, MSN, ONC 10/ 24/ 04

  2. Autoimmune and Inflammatory Disorders:Rheumatoid Arthritis Chronic systemic, inflammatory disease characterized by recurrent inflammation of connective tissue, primarily of joints (diarthroidal)and related structures.

  3. Pathophysiology Rheumatoid Arthritis • Normal antibodies (immunoglobulins) become autoantibodies and attack host tissues (RF) • Neutrophils, T cells synovial fluid cells acitavted; • Cystokines, interleukin-1 and TNR (tumor necrosing factor) alpha; chrondroytes attack cartilage; • Synovium digests cartilage; inflammatory molecules released containing interleukin-1 and TNF alpha

  4. Pathophysiology: Rheumatoid Arthritis • Pathophysiology • IgG/RF (HLA)= antigen-antibody complex • Precipitates in synovial fluid • Inflammatory response • Cartilage connective tissue primarily affected!

  5. Rheumatoid arthritis: assessment: manifestations and complications • Fatigue, weakness, pain • Joint deformity • Rheumatic nodules • Multisystem involvement

  6. How does Rheumatoid Arthritis Compare to Osteoarthritis? • Definition: *wear and tear, progressive, non-systemic, Degenerative Joint Disease (DJD) • Pathophysiology

  7. Osteoarthritis (top slide only) Identify which joints are primarily affected with osteoarthritis. What factors contribute to the development of osteoarthritis? Ankylosing spondylitis (what type of arthritis is this?)

  8. Structural changes with Osteoarthritis Early Cartilage softens, pits, frays Progressive Cartilage thinner, bone ends hypertrophy, bone spurs develop and fissures form Advanced Secondary inflammation of synovial membrane; tissue and cartilage destruction; late ankylosis

  9. What signs and symptoms does the person with osteoarthritis experience? Normal Knee structure Moderately advanced osteoarthritis Advanced osteoarthritis

  10. What symptoms/assessment for the patient with osteoarthritis? Onset of pain is insidious, individual is healthy! Pain is aching in nature; relieved by rest!. Local signs and symptoms: swelling, crepitation of joint and joint instability, asymmetrical joint involvement

  11. Deformities with Osteoarthritis Carpometacarpocarpal joint of thumb with subluxation of the first MCP Genuvarus Herberden’s nodes

  12. Diagnostic Tests None specific Late joint changes, boney sclerosis, spur formation Synovial fluid inc., minimal inflammation Gait analysis Nursing diagnosis Interventions determined by complications Supportive devices Medications (no systemic treatment with steroids) Dietary to dec. wt. Surgical Intervention (joint replacement) Teaching Osteoarthritis (review only)

  13. Comparison of RA and OA RA Cause unknown; auto-immune factor Onset sudden Remissions *Body parts affected, systemic, small joints, symmetrical Causes redness, warmth, swelling of joints Females, age 20-30; 3-1 ratio OA Cause “wear and tear”, develops slowly Non-systemic, weight bearing joints Middle-aged and elderly, males 2-1 affected Does not cause malaise Begins after 40

  14. Manifestations of RA • Systemically ill • Hematologic • Pulmonary/CV • Neurologic • Ocular symptoms (Sjorgen’s) • Skin • Musculoskeletal deformity, pain Pain! Pain! Pain

  15. Early Pannus Granulation, inflammation at synovial membrane, invades joint, softens and destroys cartilage Joints changes with RA

  16. RA • Mod advanced Pannus • joint cartilage disappears, underlying bone destroyed, joint surfaces collapse • Fibrous Ankylosis • Fibrous connective tissue replaces pannus; loss of joint otion • Bony Ankylosis • Eventual tissue and joint calcification

  17. Bilateral, symmetrical, PIP’s, MCP’s Thumb instability Swan neck, boutonniere deformity Tensynovitis Multans deformity Subcutaneous nodules Genu valgum Pes plano valgus Prominent metatarsal heads Hammer toes Joint Changes RA

  18. Assessment RA Deformities that may occur with RA Synotenovitis Ulnar drift Swan neck deformity Boutonniere deformity

  19. Mutlans deformity (rapidly progressing RA) Hitch-hiker thumb Genu valgus

  20. Subcutaneous nodules (disappear and appear without warning)

  21. Hammer toes

  22. Diagnostic Tests RA ESR elevated + RA, ^ RA titer Sed rate increased CBC C-reactive protein Dec. serum complement Synovial fluid inflammation Joint and bone Swelling,inflammation

  23. Nursing Diagnosis Comfort Physical mobility Self image Goals Team Approach Pain management Exercise Surgery Teaching Interventions RA

  24. Medications RA • ASA & NSAIDS • Corticosteroids; low dose • DMARDs (diverse group) of remitting agents: including antimalarial (hydroxychloroquine:plaquenil) *eye effects; Penicillamine (empty stomach); Gold (Auranofin) *dermatitis, blood dyscrasia; and • Immunosuppressive agents as methotrexate and cyclosporine • Biologic response modifiers • Adalimumab (Humira) • Infliximab (Remicade)

  25. Joint Protection: Do’s and Don’t’s

  26. Case Presentation; Mrs. Michaels with Rheumatoid Arthritis(PDS: Adult Health: Musculoskeletal Health: Mrs. Michaels) • Comparison to ‘usual’ course • Diagnostic tests • Nursing diagnosis • Therapies • Medications used • Exercise • Joint Protection • Resources on the Web

  27. SystemicLupus Erythematous (SLE) Chronic multisystem disease involving vascular and connective tissue Lupus Foundation

  28. Exact etiology unknown: genes (HLA), hormones, environment involved Formation auto-antibodies; immune complexes deposited Inflammatory response triggered by deposition of immune complexes (kidney, brain) Drug induced syndrome similar to SLE (Procan-SR, hydralazine, isonaiazid) Pneumonia, infections, *renal, CNS involvement!; Course of disease varies Mild Episodic Rapidly fatal Etiology and Pathophysiology SLE

  29. Types: Discoid, SLE Incidence: 1:2000 Women 1-9, child-bearing age, african americans Periods remission and exacerbation Stress Environmental factors Assessment Low grade fever Integumentary MS involvement CV Respiratory Urinary Renal failure Neurologic CNS GI Hematologic Endocrine Reproductive Manifestations/Complications of SLE

  30. Characteristic butterfly rash associated with SLE, especially discoid lupus erythematous Barry’s lupus

  31. SLE characterized by periods of remission and exacerbation. Stimulated by sunlight, stress, pregnancy, infections like strep and some drugs. Some drugs like apresoline, pronestyl, dilantin, tetracycline, phenobarbital may cause a lupus-like reaction which disappears when drug is stopped.

  32. LE cell Ant-DNA ANA, titer Anti-DNA Complement fixation decreased ESR Other (and CBC, UA) Kidney biopsy Criteria to Dx. malar, discoid rash photosensitivity arthritis renal disorder immunological disorder DNA, ANA Diagnostic Tests

  33. Nursing diagnosis See RA Impaired skin integrity Ineffective protection Impaired health maintenance Goal: control inflammation Emotional support Life Planning Required Review Medications NSAIDS (Disease modifying agents) Antimalarial drugs Corticosteroids Immunsuppressive therapy Antineoplastic drugs such as Imuran, cytoxan, cyclosporine Avoid UV Reduce stress Monitor/manage to prevent complications Therapeutic Interventions/Management SLE

  34. Clinical Background: 18 year old patient admitted with recent onset (3 months earlier) of malar rash and constitutional symptoms (weakness and malaise), now symptoms of renal failure. She reported having a 5-year history of Raynaud's phenomenon and arthralgia. Abnormal results of laboratory studies included the presence of ANA, anti-nDNA, anti-SS-A autoantibodies and a proteinuria of approximately 10 g/d.Renal biopsy revealed a Class IV lupus glomerulonephritis. What assessment data is priority: what additional date should you collect? What are the priority nursing problems? Case Study What are the priority interventions? What medications are typically used and why?

  35. Scleroderma(Systemic sclerosis) • Definition: progressive sclerosis of skin and connective tissue; fibrous and vascular changes in skin, blood vessels, muscles, synovium, internal organs. become “hide bound” • Immune-mediated disorder; genetic component

  36. Scleroderma (Systemic sclerosis) • Abnormal amounts of fibrous connective tissue deposited in skin, blood vissels, lungs, kidneys, other organs • Can be systemic or localized (CREST) syndrome

  37. CREST Syndrome • Calcinosis • Raynaud’s phenomena • Esophageal hypomotility • Sclerodactyl (skin changes of fingers) • Telangiectasia (macula-like angioma of skin) More on CREST

  38. CREST Syndrome & scleroderma Sclerodactyl (localized scleroderma of fingers) Raynaud’s disease with ischemia

  39. Typical “hide-bound” face of person with scleroderma Tissue hardens; claw-like fingers; fibrosis

  40. Manifestations & Complications (systemic) • Female 4:1 • Pain, stiffness, polyartheritis • Nausea, vomiting • Cough • Hypertension • Raynauld’s syndrome • Skin atrophy, hyperpigmented

  41. Scleroderma cont. • Esophageal hypomotility leads to frequent reflux • GI complaints common • Lung-pleural thickening and pulmonary fibrosis • Renal disease...leading cause of death!

  42. R/O autoimmune disease Radiological: pulmonary fibrosis, bone resorption, subcutaneous calcification, distal esophageal hypomotility ESR elevated CBC anemia Gammaglobulin lelels elevaed; RA present Skin biopsy to confirm What are the KEY components of care for the individual with Scleroderma? Diagnosis/Treatment Scleroderma

  43. Scleroderma: Patient Care • Do’s • Avoid cold • Provide small, frequent feedings • Protect fingers • Sit upright post meals • No fingersticks • Daily oral hygiene Resources

  44. Scleroderma: Patient Care • Medications: based upon symptoms: • Immunosuppressive agents & steroids & remitting agents • Ca channels blockers & alpha-adrenergic blockers • H2 receptor blockers • ACE inhibitors • Broad spectrum antibiotics

  45. Definitions: chronic inflammatory polyarteritis of spine Affects mostly young men Associated with HLA-B27 antiget positive antigen (90%) Pathophysiology & Manifestations Like arthritis have inflammatory changes; erosion of cartilage, ossification of joint margins; scar tissue replaces Morning backache, flexion of spine, decreased chest expansion Diagnosis ESR elevation Positive HLA-B27 antigen Vertebral changes Ankylosing Spondylitis

  46. Ankylosing Spondylitis Insidious onset Morning backache Inflammation of spine; later spine ossification Oh my back hurts!

  47. Comparison of changes with ospeoporosis and Ankylosing spondylitis Identify a PRIORITY nursing concern related to ankylosing spondylitis

  48. Management Ankylosing Spondilitis • Do’s • Maintain spine mobility • Pain management • Proper positioning • Meds for pain, inflammation

  49. Reiter’s Syndrome Reactive arthritis associated with enteric disease Lyme Disease (mimics rheumatoid disease) Caused by spirochete, borrelia burgdorferi (tick) Inflammatory disorder 3 stages Initial rash (target) Disseminated (arthitic like symptoms) Late (neurologic symptoms) Diagnosis Culture (difficult) Antibody detection Other Collagen Diseases Treatment: antibiotics (amoxicillin, vibramycin, tetracycline, etc); NSAID) Prevention

  50. Polymyositis Systemic connective tissue disorder characterized by inflamation of connective tissue and muscle fibers Autoimmune; affecting women 2:1 If muscle fiber inflammation is accompanied by skin lesion disease known as dermatomyositis Manifestations & complications Muscle pain, tenderness, rash; arthralgias; fatigue; fever and weight loss; Skeletal muscle weakness most prominent Dusky red rash over face Raynaud’s phenomenon Malignancy with dermatomyositis Diagnosis None specific Elevated CK Other Collagen Diseases

More Related